AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Statera Biopharma, Inc.
Video analysis: STAB
All videosNo video analysis for this stock yet. Request one from our team.
News: STAB
CLARIANE BNP Paribas Primary New Issues: NO STAB Notice
24/06/26 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CLARIANE SE Post-stabilisation Period Announcement NO STABILISATION CARRIED OUT [Further to the pre-stabilisation period announcement dated 23/06/26 BNP Paribas (contact: Stanford Hartman telephone: 0207 595 8222) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulation (EU/596/2014)) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
NEOPHARMED - BNP Paribas Primary New Issues: NO STAB Notice
22/06/26 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Neopharmed Gentili S.p.A.
